Miami, FL, United States of America

Alan H Gibbs


Average Co-Inventor Count = 1.7

ph-index = 3

Forward Citations = 39(Granted Patents)


Location History:

  • Miami, FL (US) (1988)
  • Spring House, PA (US) (2015 - 2019)

Company Filing History:


Years Active: 1988-2019

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Alan H. Gibbs - Innovator in Pain Management

Introduction

Alan H. Gibbs, based in Miami, FL, is a distinguished inventor recognized for his contributions in the field of pain management. With a total of four patents to his name, Gibbs's work focuses on the innovative uses of Huwentoxin-IV variants, which have significant implications for treating pain effectively.

Latest Patents

Gibbs's latest patents include groundbreaking inventions related to Huwentoxin-IV variants and their methods of use. His innovation encompasses not only the variants of Huwentoxin-IV but also the polynucleotides encoding them. These inventions detail methods of alleviating pain through peptide inhibitors of Nav1.7, showcasing a novel approach to pain relief in medical applications.

Career Highlights

Throughout his career, Alan H. Gibbs has made significant strides in the biotechnology sector. He has been associated with Janssen Biotech, Inc., where his research and innovations have contributed to the advancement of medical therapies. His extensive expertise has positioned him as a leading figure in the development of pain management solutions.

Collaborations

In his professional journey, Gibbs has collaborated with notable individuals such as Mack Flinspach and Michael J. Hunter. These collaborations have fostered a rich exchange of ideas and an environment conducive to innovation, ultimately leading to the advancement of their joint research projects.

Conclusion

Alan H. Gibbs exemplifies the spirit of innovation in the healthcare industry. Through his impressive portfolio of patents and collaborations, he continues to pave the way for advancements in pain management. His work with Huwentoxin-IV variants reflects the potential of innovative therapies to enhance patient care and improve quality of life.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…